Compliance simplified.
Latest Publications
U.S. Court of Appeals, D.C. Circuit Upholds Decision Against Drug Pricing Rule
John Patrick Oroho Interview with Global Business Reports US Biopharmaceuticals 2020
John Oroho
Utah Insurance Department Issues Bulletin Regarding Prescription Drug Price Transparency Act; Contact Information Due June 1, 2020
Communication During a Pandemic
Alicia Whittlesey
Nevada Department of Health and Human Services Extends Deadline For Essential Drug Report to April 16, 2020
Utah Has Introduced Legislation Requiring Manufacturers to Provide a List of Pharmaceutical Sales Representatives; Establishes Reporting and Price Disclosure Requirements
West Virginia Introduces Legislation to Require $55,000 Opioid License Fee, Additional Product Registration Fee, and Controlled Substance Distribution Reporting
Washington Introduces Legislation Establishing an Impact Fee for Opioid Manufacturers
Maine Legislation Requiring Opioid Distribution Reporting and Payment of Manufacturer Fees Became Law Without the Governor's Signature
1-10 of 65